Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Methylenetetrahydrofolate reductase C677T polymorphism is associated with estimated glomerular filtration rate in hypertensive Chinese males

BMC Medical Genetics201213:74

DOI: 10.1186/1471-2350-13-74

Received: 14 December 2011

Accepted: 30 April 2012

Published: 16 August 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
14 Dec 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Feb 2012 Reviewed Reviewer Report - Keiji Yoshioka
17 Feb 2012 Reviewed Reviewer Report - Qurratulain Hasan
13 Mar 2012 Author responded Author comments - qing dong
Resubmission - Version 3
13 Mar 2012 Submitted Manuscript version 3
11 Apr 2012 Reviewed Reviewer Report - Keiji Yoshioka
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
30 Apr 2012 Editorially accepted
16 Aug 2012 Article published 10.1186/1471-2350-13-74

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University
(2)
School of Health Administration, Anhui Medical University
(3)
Department of Neurology, First People’s Hospital
(4)
Department of Neurology, Guangdong Traditional Chinese Medicine Hospital
(5)
Lianyungang Center for Advanced Research in Cardiovascular Diseases
(6)
Department of Cardiology, Second People’s Hospital
(7)
Department of Cardiology, Peking University First Hospital
(8)
Institute of Biomedicine, Shenzhen University
(9)
Department of Cardiology, Peking University People’s Hospital
(10)
Division of Hypertension, Fu-wai Hospital
(11)
Division of Epidemiology and Biostatistics, University of Illinois at Chicago School of Public Health
(12)
Institute of Nephrology, Southern Medical University

Advertisement